MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Neuraxis (NRXS) Ownership - Who owns Neuraxis?
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Profile
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.09M
P/E Ratio
N/A
Total Cash
3.7M
Projected Growth
N/A
Total Debt
473.41K
Revenue
2.69M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.51
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
Fundamentals
NRXS
Capitalization
23.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.7M
Total Cash/Share
0.51
Total Debt
473K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.41%
Revenue
2.69M
ROE
N/A
Book Value
2.06M
P/B Ratio
90.91
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.99K
Current Ratio
1.75
Current Revenue Per Employee
40061.32
Dividends Per Share - Security
N/A
EBITDA
-7.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.20
Revenue To Assets
-320.97
Shares Held By Institutions
1.32M
Shares Outstanding - Current
7.22M
Total Liabilities
2.69M
Total Volume MTD
N/A
Value
-1
Gain YTD
36.170
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com